BiotechTube

LAS41003 + LAS189962 + LAS189961

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Eczema

Conditions

Eczema

Trial Timeline

Nov 1, 2009 → Jun 1, 2010

NCT ID
NCT01020994

About LAS41003 + LAS189962 + LAS189961

LAS41003 + LAS189962 + LAS189961 is a phase 2 stage product being developed by Almirall for Eczema. The current trial status is completed. This product is registered under clinical trial identifier NCT01020994. Target conditions include Eczema.

What happened to similar drugs?

2 of 13 similar drugs in Eczema were approved

Approved (2) Terminated (2) Active (9)
🔄Colloidal Oatmeal CreamJohnson & JohnsonPhase 3
✅Pimecrolimus cream 1%NovartisApproved
🔄AbrocitinibPfizerPhase 3
🔄alitretinoin + PlaceboGSK plcPhase 3
✅DupilumabRegeneron PharmaceuticalsApproved
❌Ruxolitinib cream + VehicleIncytePhase 3
❌Ruxolitinib cream + VehicleIncytePhase 3

Hype Score Breakdown

Clinical
12
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01102387Phase 2Completed
NCT01020994Phase 2Completed

Competing Products

20 competing products in Eczema

See all competitors
ProductCompanyStageHype Score
1% Colloidal Oatmeal BalmJohnson & JohnsonPre-clinical
18
Colloidal Oatmeal CreamJohnson & JohnsonPhase 3
40
Pimecrolimus cream 1%NovartisApproved
43
AbrocitinibPfizerPhase 3
47
Dupilumab + PlaceboSanofiPhase 2
31
Amlitelimab + PlaceboSanofiPhase 2
35
alitretinoin + PlaceboGSK plcPhase 3
40
DupilumabRegeneron PharmaceuticalsApproved
39
Adventan® (methylprednisolone aceponate 0,1%)BayerPhase 1
26
Ruxolitinib cream + VehicleIncytePhase 3
29
Ruxolitinib cream + VehicleIncytePhase 2
32
Ruxolitinib cream + VehicleIncytePhase 3
29
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%Arcutis BiotherapeuticsPhase 3
34
Roflumilast Cream + Vehicle creamArcutis BiotherapeuticsPhase 3
34
ARQ-151 cream 0.05%Arcutis BiotherapeuticsPhase 2
29
Roflumilast Cream 0.05% + Vehicle CreamArcutis BiotherapeuticsPhase 3
34
Roflumilast Cream 0.15% + Vehicle CreamArcutis BiotherapeuticsPhase 3
34
ARQ-151 cream 0.15% + ARQ-151 cream 0.05%Arcutis BiotherapeuticsPhase 1
23
ARQ-252 cream 0.3% + ARQ-252 cream 0.1% + ARQ-252 Vehicle CreamArcutis BiotherapeuticsPhase 1/2
26
LAS 41002 + ActiveAlmirallPhase 2
29